These findings suggest that SP alleviates myocardial fibrosis in DCM by inhibiting the activation of the TGF-β1/Smads signaling pathway and reducing the proliferation, differentiation, and collagen secretion of CFs. The gene discussed is TGFB1; the disease is Myocardial fibrosis.